Category: Drug Discovery
Drug Discovery market research reports by Icon Group International, Inc.
-
The 2025-2030 World Outlook for Infectious Disease Drugs
The 2025-2030 World Outlook for Infectious Disease Drugs This study covers the world outlook for infectious disease drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millio ... Read More
-
The 2025-2030 World Outlook for Oral Proteins and Peptides
The 2025-2030 World Outlook for Oral Proteins and Peptides This study covers the world outlook for oral proteins and peptides across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mi ... Read More
-
The 2025-2030 World Outlook for Colorectal Cancer Therapeutics
The 2025-2030 World Outlook for Colorectal Cancer Therapeutics This study covers the world outlook for colorectal cancer therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in questio ... Read More
-
The 2025-2030 World Outlook for Oncology Small Molecule Drug Discovery
The 2025-2030 World Outlook for Oncology Small Molecule Drug Discovery This study covers the world outlook for oncology small molecule drug discovery across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the co ... Read More
-
The 2025-2030 World Outlook for Immunoglobulin Plasma Therapeutics
The 2025-2030 World Outlook for Immunoglobulin Plasma Therapeutics This study covers the world outlook for immunoglobulin plasma therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Therapeutics Proteins
The 2025-2030 World Outlook for Therapeutics Proteins This study covers the world outlook for therapeutics proteins across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Neurtrophic Keratitis
The 2025-2030 World Outlook for Neurtrophic Keratitis This study covers the world outlook for neurtrophic keratitis across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Neuroprotective Agents
The 2025-2030 World Outlook for Neuroprotective Agents This study covers the world outlook for neuroprotective agents across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions o ... Read More
-
The 2025-2030 World Outlook for Oligonucleotide Therapeutics
The 2025-2030 World Outlook for Oligonucleotide Therapeutics This study covers the world outlook for oligonucleotide therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (i ... Read More
-
The 2025-2030 World Outlook for RNA Therapeutics
The 2025-2030 World Outlook for RNA Therapeutics This study covers the world outlook for RNA therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dolla ... Read More
-
The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics
The 2025-2030 World Outlook for Cancer Supportive Care Therapeutics This study covers the world outlook for cancer supportive care therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country ... Read More
-
The 2025-2030 World Outlook for Metabolomics Products
The 2025-2030 World Outlook for Metabolomics Products This study covers the world outlook for metabolomics products across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Metabolomics Technologies
The 2025-2030 World Outlook for Metabolomics Technologies This study covers the world outlook for metabolomics technologies across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in mill ... Read More
-
The 2025-2030 World Outlook for Basal Cell Carcinoma Treatments
The 2025-2030 World Outlook for Basal Cell Carcinoma Treatments This study covers the world outlook for basal cell carcinoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Respiratory Disorders Therapeutics
The 2025-2030 World Outlook for Respiratory Disorders Therapeutics This study covers the world outlook for respiratory disorders therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in ... Read More
-
The 2025-2030 World Outlook for Rheumatic Disorder Therapeutics
The 2025-2030 World Outlook for Rheumatic Disorder Therapeutics This study covers the world outlook for rheumatic disorder therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Scleroderma Diagnostics and Therapeutics
The 2025-2030 World Outlook for Scleroderma Diagnostics and Therapeutics This study covers the world outlook for scleroderma diagnostics and therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for MRSA Drugs
The 2025-2030 World Outlook for MRSA Drugs This study covers the world outlook for MRSA drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the per ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma This study covers the world outlook for non-Hodgkin lymphoma across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U. ... Read More
-
The 2025-2030 World Outlook for Sequencing and Target Data Analysis Drug Discovery Informatics
The 2025-2030 World Outlook for Sequencing and Target Data Analysis Drug Discovery Informatics This study covers the world outlook for sequencing and target data analysis drug discovery informatics across more than 190 countries. For each year reported, estimates are given for the latent demand, or ... Read More
-
The 2025-2030 World Outlook for Hypertrophic Cardiomyopathy Therapeutics
The 2025-2030 World Outlook for Hypertrophic Cardiomyopathy Therapeutics This study covers the world outlook for hypertrophic cardiomyopathy therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for th ... Read More
-
The 2025-2030 World Outlook for Oncology Therapeutics
The 2025-2030 World Outlook for Oncology Therapeutics This study covers the world outlook for oncology therapeutics across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of ... Read More
-
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments
The 2025-2030 World Outlook for Non-Hodgkin Lymphoma Treatments This study covers the world outlook for non-Hodgkin lymphoma treatments across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in quest ... Read More
-
The 2025-2030 World Outlook for Cloud-Based Drug Discovery Platforms for Pharmaceutical Vendors
The 2025-2030 World Outlook for Cloud-Based Drug Discovery Platforms for Pharmaceutical Vendors This study covers the world outlook for cloud-based drug discovery platforms for pharmaceutical vendors across more than 190 countries. For each year reported, estimates are given for the latent demand, o ... Read More
-
The 2025-2030 World Outlook for Neurodegenerative Drugs
The 2025-2030 World Outlook for Neurodegenerative Drugs This study covers the world outlook for neurodegenerative drugs across more than 190 countries. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions ... Read More
Research Assistance
